Med BioGene Inc. (MBI.V)

TSXV - TSXV Delayed Price. Currency in CAD
0.040.00 (0.00%)
At close: 3:40 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.04
Bid0.04 x
Ask0.04 x
Day's Range0.04 - 0.04
52wk Range0.04 - 0.09
1y Target EstN/A
Market Cap3.5M
P/E Ratio (ttm)-20.00
Avg Vol (3m)37,622
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Marketwired10 months ago

    Med BioGene Inc. Announces Commercialization Status of GeneFX Lung(R)

    Med BioGene Inc. is very pleased to be able to confirm that our licensee, Helomics has advised us that logistical procedures necessary for the first commercial application of GeneFX Lung will commence ...

  • Marketwired11 months ago

    Med BioGene Inc.: Grant of Stock Options

    Med BioGene Inc. announces that it has granted stock options to directors and senior officers to purchase up to an aggregate of 3,750,000 common shares in the capital of the Company. The options are exercisable ...

  • Capital Cubelast year

    Med BioGene, Inc. Earnings Q2*, 2015

    *Disclaimer : Capital Cube uses calendar year to determine the quarters for reporting purposes. This may vary for issuers. The analysis represents the most recent quarterly reporting from the issuer.Med BioGene, Inc. reports preliminary financial results for the quarter ended March 31, 2015.We analyze the earnings along side the following peers of Med Biogene Inc (Read more...) The post Med BioGene, Inc. Earnings Q2*, 2015 appeared first on CapitalCube.